Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GABBR1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | F2R | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
mRNA | VPS33B | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
mRNA | SLTM | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | ITGB1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | DYNLL2 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
mRNA | RPL18 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | BIRC8 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | ZBED2 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | SLC38A2 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |